Kyung Nam Pharm Co Ltd (053950) - Total Liabilities

Latest as of June 2026: ₩25.73 Billion KRW ≈ $17.44 Million USD

Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has total liabilities worth ₩25.73 Billion KRW (≈ $17.44 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Kyung Nam Pharm Co Ltd to evaluate the company's liquid asset resilience ratio.

Kyung Nam Pharm Co Ltd - Total Liabilities Trend (2007–2025)

This chart illustrates how Kyung Nam Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Kyung Nam Pharm Co Ltd total assets.

Kyung Nam Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Distil Plc LSE:DIS	UK	GBX951.00K
Tirupati Graphite plc LSE:TGR	UK	GBX6.15 Million
SRAX Inc NASDAQ:SRAX	USA	$27.32 Million
Hana Microelectronics Public Company Limited F:HAA1	Germany	€4.68 Billion
Eos Energy Enterprises Inc NASDAQ:EOSEW	USA	$2.65 Billion
Cloudcoco Group PLC LSE:CLCO	UK	GBX1.77 Million
KRUNG THAI -FGN- BA 515 F:KTB1	Germany	€3.45 Trillion

Liability Composition Analysis (2007–2025)

This chart breaks down Kyung Nam Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Kyung Nam Pharm Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyung Nam Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyung Nam Pharm Co Ltd (2007–2025)

The table below shows the annual total liabilities of Kyung Nam Pharm Co Ltd from 2007 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩47.33 Billion ≈ $32.08 Million	-7.85%
2024-12-31	₩51.36 Billion ≈ $34.81 Million	-33.10%
2023-12-31	₩76.78 Billion ≈ $52.03 Million	+72.54%
2022-12-31	₩44.50 Billion ≈ $30.16 Million	-35.78%
2020-12-31	₩69.29 Billion ≈ $46.96 Million	+422.30%
2019-12-31	₩13.27 Billion ≈ $8.99 Million	-45.28%
2018-12-31	₩24.24 Billion ≈ $16.43 Million	-14.49%
2016-12-31	₩28.35 Billion ≈ $19.22 Million	-57.82%
2010-12-31	₩67.22 Billion ≈ $45.56 Million	+7.72%
2009-12-31	₩62.41 Billion ≈ $42.29 Million	+43.46%
2008-12-31	₩43.50 Billion ≈ $29.48 Million	+37.89%
2007-12-31	₩31.55 Billion ≈ $21.38 Million	--

About Kyung Nam Pharm Co Ltd

KQ:053950 Korea

Market Cap

$14.62K

₩21.58 Million KRW

Market Cap Rank

#31787 Global

#2121 in Korea

Share Price

₩2280.00

Change (1 day)

-0.65%

52-Week Range

₩1435.00 - ₩2295.00

All Time High

₩2295.00